Abstract:Abstract NKT cells from naïve mice are mainly CD4+ or CD4−CD8−. However, it has been reported that CD8+ NKT cells can be expanded in vitro from splenocytes, bone marrow cells and thymocytes of C57BL/6 (B6) mice by stimulation with anti-CD3 mAb and cytokines, and that the expanded CD8+ NKT cells mediate strong graft-vs.-leukemic (GVL) effects without severe GVHD after adoptive transfer into allogeneic mice. We now describe the presence of CD8+NK1.1+ cells in recipient livers (approximately 2–6%), but not in other tissues (spleen, lung, bone marrow, thymus and PBMC), in various allogeneic hematopoietic cell transplantation (allo-HCT) models. The generation of CD8+NK1.1+ cells is likely a consequence of alloresponses, as these cells were not detected in the liver of syngeneic HCT controls. Flow cytometric analysis confirmed that these cells are CD1d-independent, TCRαβ+ T cells with a memory phenotype (CD44+ and CD62L−), and do not express CD49b, Ly-49C/I, Ly-49G2, or Ly-49D. In a sublethally (6 Gy)-irradiated B6-to-B6D2F1 allo-HCT model, NK1.1+ CD8 T cells became detectable by week 2, increased in number until approximately week 8, and gradually declined thereafter but were still detectable in the liver at day 100 after allo-HCT. By using CD45.1 and CD45.2 congeneic donors, we determined that the majority of NK1.1+ CD8 T cells were derived from the donor splenocytes. Furthermore, depletion of CD8+, but not NK1.1+, cells from the donor splenocytes prior to transplantation prevented the generation of NK1.1+ CD8 T cells, indicating that these cells were derived from donor NK1.1−CD8+ splenic T cells. Our data demonstrate that donor CD8 T cells can acquire NK1.1 expression upon activation in allo-HCT recipients, and that these NK1.1+ CD8 T cells maintain a memory phenotype and persist in the recipients with preferential accumulation in the liver. Studies are currently in progress to determine the role of activated donor NK1.1+ CD8 T cells in GVHD and GVL effects.

Mice CD8+NK1.1+NKT Cells Amplified in Vitro

Expansion of NK Cells by Engineered K562 Cells Co-Expressing 4-1BBL and Mmica, Combined with Soluble IL-21.

Morphology and differentiation pathway of superantigen SEB-activated NKT subsets]

Characterization of NK1.1+ CD8 T Cells in Allogeneic Hematopoietic Cell Transplantation Recipients

Pathogen-expanded CD11b+ invariant NKT cells feedback inhibit T cell proliferation via membrane-bound TGF-β1

Mouse CD8+NKT-like Cells Exert Dual Cytotoxicity Against Mouse Tumor Cells and Myeloid-Derived Suppressor Cells.

CD8+NKT-like Cells Regulate the Immune Response by Killing Antigen-Bearing DCs

Activated CD8 T Cells Acquire NK1.1 Expression and Preferentially Locate in the Liver in Mice after Allogeneic Hematopoietic Cell Transplantation.

Efficient Expansion of the Cytokine-Induced Natural Killer Cells from Human Peripheral Blood in Vitro

Purification and Expansion of Mouse Invariant Natural Killer T Cells for in vitro and in vivo Studies

[Separation and Amplification of CD4(+)CD25(+) Regulatory T Cells from Sensitized Mice].

NKT Cells in Mice Originate from Cytoplasmic CD3-Positive, CD4−CD8− Double-Negative Thymocytes That Express CD44 and IL-7Rα

Trained Immunity of IL-12-, IL-15-, and IL-18-Induced CD3+CD56+ NKT-Like Cells

Subpopulations,phenotypes and Biological Characterization of Human NKT Cells in PBMCs

Development of CD4-CD8- alpha beta TCR+NK1.1+ T lymphocytes: thymic selection by self antigen.

Mechanism of Enhancement of the CTL Activity in Mice Co-Expressing CD80, CD86 and CD137Lgenes

Comparison of CD8~+ NKT Cells and CTL in Anti-Tumor Effects

An Optimized Method for Isolating and Expanding Invariant Natural Killer T Cells from Mouse Spleen

IL-18 primes T cells with an antigen-inexperienced memory phenotype for proliferation and differentiation into effector cells through Notch signaling

Characterization of a Murine Thymic CD4 + T Cell Subset-Tcrαβ + 3G11 − 6C10 − CD4 + CD8 − Thymocytes

TGF-β1 Induces Differentiation of CD4+ CD25- T Cells into CD4+ CD25+ Regulatory T Cells